$heff's $tation of $tocks & $olid DD

[momentum74]

DNAI 7.07 investor presentation, Initial phase II results coming in the second quarter. They have multiple trials occurring. Long for a bounce swing trade. avg price is 7.15

Investor presentation
http://pronai.investorroom.com/index.php?s=123

"We recently announced the initiation of Brighton, a Phase 2 monotherapy trial evaluating our lead DNAi-based product candidate PNT2258 in approximately 50 patients with Richter's transformation, a rare form of lymphoma with no approved treatments. We also continue to enroll patients in Wolverine, our Phase 2 monotherapy trial of PNT2258 in patients with relapsed or refractory diffuse large B-cell lymphoma, DLBCL, and we remain on track to report initial data from this trial in the second quarter of 2016," said Dr. Nick Glover, President and CEO of ProNAi Therapeutics. "With these trials underway, we are now preparing planned Phase 2 trials of PNT2258 in combinations with other therapeutics in patients with earlier lines of DLBCL and anticipate initiating the first of these trials in the first half of 2016."


On 02/16 many updates were filed on institutional ownership .

http://www.nasdaq.com/symbol/dnai/sec-filings


PRONAI THERAPEUTICS INC
Filer : FRAZIER HEALTHCARE VI, L.P. SC 13G 2/16/2016

PRONAI THERAPEUTICS INC
Filer : ORBIMED ADVISORS LLC SC 13G 2/16/2016 .

PRONAI THERAPEUTICS INC
Filer : FLYNN JAMES E SC 13G/A 2/16/2016.

PRONAI THERAPEUTICS INC
Filer : VIVO VENTURES VII, LLC SC 13G 2/16/2016

PRONAI THERAPEUTICS INC
Filer : FMR LLC SC 13G/A 2/12/2016